Reaction
Pertussis reporting signals
As of the last recalculation, Pertussis appears in 1,035 FAERS reports alongside 8 co-occurring drug terms. The strongest observed disproportionality signal is PALIVIZUMAB (PRR 37.6).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Palivizumab | 28 | 37.6 | 37.7 |
| Ciclesonide | 12 | 17.9 | 17.9 |
| Cladribine | 6 | 12.6 | 12.6 |
| Obinutuzumab | 8 | 9.8 | 9.9 |
| Calcium, Magnesium, Potassium, And Sodium Oxybates | 4 | 9.4 | 9.4 |
| Ustekinumab | 34 | 6.9 | 6.9 |
| Ofatumumab | 10 | 6.1 | 6.1 |
| Bimekizumab | 4 | 3.8 | 3.8 |